Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome
<p>Abstract</p> <p>Background</p> <p>Metabolic syndrome (MetS) is associated with an increased risk of the development of atherosclerotic cardiovascular disease (CVD). Interleukin-18 (IL-18), which is a pleiotropic proinflammatory cytokine with important regulatory func...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-01-01
|
| Series: | Nutrition & Metabolism |
| Online Access: | http://www.nutritionandmetabolism.com/content/8/1/3 |